GlassScriptPhysician profile
Michael F Buckley
NPI 1184691685
$2,589.10
in general payments reported to CMS, 2019-2025
32 companies · $453 in 2025
The $453 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $388 · 2020: $233 · 2021: $318 · 2022: $325 · 2023: $560 · 2024: $313 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,325.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $446.83 | 2019-2025 | |
| Abbvie INC. | $316.56 | 2019-2023 | Lo Loestrin Fe, Orilissa, Ubrelvy |
| Mayne Pharma Commercial LLC | $152.17 | 2019-2025 | |
| Organon LLC | $144.95 | 2022-2025 | Nexplanon |
| Medtronic, INC. | $138.17 | 2021 | |
| Coopersurgical, INC. | $134.89 | 2019-2025 | Paragard T 380a, Paragard T 380a, Endosee |
| Hologic Sales and Service, LLC | $129.73 | 2020-2025 | Acessa Provu System, Myosure Tissue Removal Device |
| Biogen, INC. | $128.36 | 2024-2025 | Zurzuvae |
| Pfizer INC. | $96.92 | 2019-2025 | |
| Exeltis, USA INC. | $91.44 | 2020-2023 | Slynd |
| Aspira Women'S Health INC | $88.29 | 2021-2023 | Ova1 |
| Sumitomo Pharma America, INC. | $87.56 | 2023-2024 | Myfembree, Gemtesa |
| Minerva Surgical, INC | $84.63 | 2019-2023 | |
| Evofem Biosciences, INC. | $63.17 | 2021-2025 | Solosec, Phexx, Phexxi |
| Myovant Sciences INC. | $57.07 | 2021-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $51.93 | 2023-2024 | Veozah |
| Therapeuticsmd, INC. | $40.80 | 2019-2021 | |
| Scynexis, INC. | $40.50 | 2022 | |
| Amag Pharmaceuticals, INC. | $37.93 | 2019 | |
| Merck Sharp & Dohme LLC | $37.15 | 2019-2020 | |
| Avion Pharmaceuticals | $28.19 | 2020 | |
| Lupin INC. | $27.54 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $26.24 | 2019 | |
| Allergan, INC. | $22.53 | 2019-2020 | |
| Daiichi Sankyo INC. | $18.17 | 2021 | |
| Lilly USA, LLC | $16.95 | 2020 | |
| Duchesnay USA Incorporated | $16.90 | 2019 | |
| Lsi Solutions INC | $16.39 | 2024 | Fornisee |
| Exact Sciences Corporation | $16.34 | 2023 | Cologuard Collection Kit |
| Sage Therapeutics, LLC | $15.99 | 2022 | |
| Laborie Medical Technologies Corp. | $14.81 | 2023 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Buckley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.